Improving clinical trial interpretation with ACCEPT analyses.
作者信息
Clements Michelle N, White Ian R, Copas Andrew J, Cornelius Victoria, Cro Suzie, Dunn David T, Quartagno Matteo, Turner Rebecca M, Tweed Conor D, Walker A Sarah
机构信息
MRC Clinical Trials Unit at UCL, London, UK.
Imperial Clinical Trials Unit, London, UK.
出版信息
NEJM Evid. 2022 Jul 26;1(8). doi: 10.1056/EVIDctw2200018. eCollection 2022 Aug.
Abstract
摘要
相似文献
1
Improving clinical trial interpretation with ACCEPT analyses.通过ACCEPT分析改进临床试验解读。
NEJM Evid. 2022 Jul 26;1(8). doi: 10.1056/EVIDctw2200018. eCollection 2022 Aug.
2
ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT).ACCEPT 2·0：重新校准并外部验证慢性阻塞性肺疾病急性加重预测工具（ACCEPT）
EClinicalMedicine. 2022 Jul 22;51:101574. doi: 10.1016/j.eclinm.2022.101574. eCollection 2022 Sep.
3
Assessing the effectiveness of artificial intelligence (AI) in prioritising CT head interpretation: study protocol for a stepped-wedge cluster randomised trial (ACCEPT-AI).评估人工智能（AI）在优先进行 CT 头部解读中的效果：一项递进式楔形集群随机试验的研究方案（ACCEPT-AI）。
BMJ Open. 2024 Jun 16;14(6):e078227. doi: 10.1136/bmjopen-2023-078227.
4
Implementation of a standardised accept note to improve communication during inter-hospital transfer: a prospective cohort study.实施标准化接受单以改善医院间转院时的沟通：一项前瞻性队列研究。
BMJ Open Qual. 2023 Oct;12(4). doi: 10.1136/bmjoq-2023-002518.
5
Item Reduction, Scoring, and First Validation of the ACCEPTance by the Patients of their Treatment (ACCEPT©) Questionnaire.患者对其治疗的接受度（ACCEPT©）问卷的项目缩减、评分及首次验证
Patient. 2017 Feb;10(1):81-92. doi: 10.1007/s40271-016-0187-7.
6
Can preventive care activities in general practice be sustained when financial incentives and external audit plus feedback are removed? ACCEPt-able: a cluster randomised controlled trial protocol.当经济激励措施以及外部审计与反馈被取消后，全科医疗中的预防保健活动能否持续开展？可接受性：一项整群随机对照试验方案。
Implement Sci. 2016 Sep 13;11(1):122. doi: 10.1186/s13012-016-0489-0.
7
Impact of the normativeness and intelligibility of privacy interpretation information on the willingness to accept targeted advertising -A cognitive load perspective.隐私解释信息的规范性和可理解性对接受定向广告意愿的影响——认知负荷视角
Curr Psychol. 2023 Feb 16:1-15. doi: 10.1007/s12144-023-04325-6.
8
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial.接受——将阿卡替尼与利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松（R-CHOP）联合用于弥漫性大 B 细胞淋巴瘤（DLBCL）：一项 Ib/II 期开放标签非随机临床试验的研究方案。
F1000Res. 2020 Aug 7;9:941. doi: 10.12688/f1000research.22318.1. eCollection 2020.
9
Parent reports on willingness to accept childhood immunizations during urgent care visits.家长关于在紧急护理就诊期间接受儿童免疫接种意愿的报告。
Pediatrics. 1998 Oct;102(4):E47. doi: 10.1542/peds.102.4.e47.
10
Patients' willingness to accept expanded criteria donor liver transplantation.患者对扩大标准供肝肝移植的接受意愿。
Am J Transplant. 2011 Aug;11(8):1705-11. doi: 10.1111/j.1600-6143.2011.03592.x. Epub 2011 Jun 14.
引用本文的文献
1
Past, present, and future of Phase 3 vaccine trial design: rethinking statistics for the 21st century.3期疫苗试验设计的过去、现在与未来：重新思考21世纪的统计学方法
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae104.
2
Inhaled Nitric Oxide ReDuce postoperatIve pulmoNAry complicaTions in patiEnts with recent COVID-19 infection (INORDINATE): protocol for a randomised controlled trial.吸入一氧化氮降低近期 COVID-19 感染患者术后肺部并发症（过度）：一项随机对照试验的方案。
BMJ Open. 2024 Mar 14;14(3):e077572. doi: 10.1136/bmjopen-2023-077572.
3
Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial.住院新生儿使用或不使用润肤剂的全身葡萄糖酸氯己定清洗的安全性和有效性（NeoCHG）：一项多中心、随机、开放标签、析因性试点试验。
EClinicalMedicine. 2024 Feb 25;69:102463. doi: 10.1016/j.eclinm.2024.102463. eCollection 2024 Mar.
4
Non-randomised feasibility study of training workshops for Talking Therapies service high-intensity therapists to optimise depression and anxiety outcomes for individuals with co-morbid personality difficulties: a study protocol.针对谈话治疗服务中的高强度治疗师开展培训工作坊以优化共病性人格障碍个体的抑郁和焦虑结局的非随机可行性研究：研究方案
Pilot Feasibility Stud. 2023 Oct 5;9(1):170. doi: 10.1186/s40814-023-01394-z.
5
Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes.实用的贝叶斯样本量确定方法在二分类结局非劣效临床试验中的应用。
Stat Med. 2023 Apr 15;42(8):1127-1138. doi: 10.1002/sim.9661. Epub 2023 Jan 20.
本文引用的文献
1
New Guidelines for Statistical Reporting in the .关于……的统计报告新指南 （原文中“in the.”后面内容缺失，翻译可能不太完整准确）
N Engl J Med. 2019 Jul 18;381(3):285-286. doi: 10.1056/NEJMe1906559.
2
Scientists rise up against statistical significance.科学家们奋起反对统计显著性。
Nature. 2019 Mar;567(7748):305-307. doi: 10.1038/d41586-019-00857-9.
3
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.一项针对耐利福平结核病的较短疗程的试验。
N Engl J Med. 2019 Mar 28;380(13):1201-1213. doi: 10.1056/NEJMoa1811867. Epub 2019 Mar 13.
4
Perioperative haemodynamic therapy for major gastrointestinal surgery: the effect of a Bayesian approach to interpreting the findings of a randomised controlled trial.胃肠道大手术围手术期血液动力学治疗：对一项随机对照试验结果进行贝叶斯解释的效果。
BMJ Open. 2019 Mar 7;9(3):e024256. doi: 10.1136/bmjopen-2018-024256.
5
Oral versus Intravenous Antibiotics for Bone and Joint Infection.口服与静脉用抗生素治疗骨与关节感染。
N Engl J Med. 2019 Jan 31;380(5):425-436. doi: 10.1056/NEJMoa1710926.
6
Superiority and non-inferiority: two sides of the same coin?优越性与非劣效性：同一枚硬币的两面？
Trials. 2018 Sep 17;19(1):499. doi: 10.1186/s13063-018-2885-z.
7
Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.6小时龄后开始治疗性低温对缺氧缺血性脑病新生儿死亡或残疾的影响：一项随机临床试验
JAMA. 2017 Oct 24;318(16):1550-1560. doi: 10.1001/jama.2017.14972.
8
Assessment of second-line antiretroviral regimens for HIV therapy in Africa.评估在非洲用于 HIV 治疗的二线抗逆转录病毒方案。
N Engl J Med. 2014 Jul 17;371(3):234-47. doi: 10.1056/NEJMoa1311274.
9
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study.利托那韦增强洛匹那韦/利托那韦加核苷或核苷酸逆转录酶抑制剂与利托那韦增强洛匹那韦/利托那韦加雷特格韦用于治疗标准一线抗逆转录病毒治疗方案病毒学失败的成人 HIV-1 感染（二线治疗）：一项随机、开放标签、非劣效性研究。
Lancet. 2013 Jun 15;381(9883):2091-9. doi: 10.1016/S0140-6736(13)61164-2.
10
Assessing noninferiority in a three-arm trial using the Bayesian approach.使用贝叶斯方法评估三臂试验中的非劣效性。
Stat Med. 2011 Jul 10;30(15):1795-808. doi: 10.1002/sim.4244. Epub 2011 Apr 26.
Zotero 插件